Bristol-Myers Squibb program on beta3-adrenoceptor agonists outlined at ACS Aug. 27, 1998 No Comments
GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride Aug. 27, 1998 No Comments
Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential Aug. 26, 1998 No Comments
RSS